Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

Corlanor (ivabradine) has been approved by the U.S. Food and Drug Administration to treat chronic heart failure

FDA Approves Corlanor for Chronic Heart Failure

0
Works by decreasing heart rate; first approved product in this drug class
The first U.S. generic version of Copaxone (glatiramer acetate injection) has been approved by the Food and Drug Administration to treat multiple sclerosis.

FDA: Generic Copaxone Approved for Multiple Sclerosis

0
FDA reviewed additional information to ensure generic is as safe and effective as brand-name drug
A new breath test (the Gastric Emptying Breath Test) has been approved by the U.S. Food and Drug Administration to aid in the diagnosis of gastroparesis.

FDA Approves New Test That Helps Diagnose Gastroparesis

0
Test is less invasive and can be administered in the physician's office
The Impella 2.5 System has been approved by the U.S. Food and Drug Administration to maintain stable heart function and blood circulation during high-risk cardiac operations

FDA Approves New Miniature Blood Pump System

0
Maintains circulation during high-risk percutaneous coronary intervention procedures
The U.S. Food and Drug Administration said Tuesday that use of the CoreValve "valve-in-valve" aortic replacement has been expanded to include people at extreme risk for serious complications from traditional open-heart surgery.

FDA Expands Approval for ‘Valve in Valve’ Aortic Replacement

0
Now includes people at risk for open-heart surgery complications
Anthrasil

FDA Approves New Treatment for Anthrax

0
FDA cites preparedness for intentional release of anthrax
U.S. Food and Drug Administration approval of Eylea (aflibercept) has been expanded to treat diabetic retinopathy among people with diabetic macular edema

FDA: Eylea Approval Expanded to Include Diabetic Retinopathy

0
Among people with diabetic macular edema
Cholbam (cholic acid) capsules have been approved by the U.S. Food and Drug Administration to treat adults and children with bile acid synthesis disorders and peroxisomal disorders

FDA Approves Cholbam for Rare Bile Acid Synthesis Disorders

0
Drug is approved as an oral treatment for children aged 3 weeks and older, and adults
The U.S. Food and Drug Administration has issued final recommendations for the cleaning and sterilization of medical devices used in invasive procedures. The updated rules

FDA Updates Recs for Cleaning of Reusable Med Devices

0
Updated rules in response to contaminated duodenoscopes
Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma.

FDA Approves Unituxin for High-Risk Neuroblastoma

0
First approval for a therapy aimed specifically to treat the rare pediatric cancer